METIS TECHBIO-P(07666.HK) closed 12.7% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends
NewTimeSpace News: By the close of trading on Sep 17, 2026, METIS TECHBIO-P(07666.HK) saw a gain of 12.7% in its share price, closing at HKD 15.53. During the session, it reached an intraday high of HKD 15.99 and touched an intraday low of HKD 13.5. The full-day turnover stood at HKD 219.98 million, with significant volume growth, with the latest market capitalization at HKD 16.82 billion.
On the sector front, the Hang Seng Pharmaceuticals & Biotechnology Sector, to which METIS TECHBIO-P belongs, showed an overall divergence trend, with 96 stocks advancing and 51 stocks declining.Among the gainers, GENSCRIPT BIO closed higher by 14.31%, METIS TECHBIO-P closed higher by 12.7%, XUANZHUBIO-B closed higher by 11.81%, REGENT PACIFIC closed higher by 9.82%, WAI YUEN TONG closed higher by 8.82%.Among the decliners, TRANSCENTA-B closed lower by 10.27%, SINCO PHARMA closed lower by 9.33%, PURAPHARM closed lower by 9.09%, UNI HEALTH closed lower by 7.75%, MEGA GENOMICS closed lower by 7.73%.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Hong Kong Recently Listed Stocks Daily Report: CREALIGHTS Rises 13.86%, Z.AI Tops Turnover at HKD 7.570 Billion - 20260917
- METIS TECHBIO-P (07666.HK): Added as Hang Seng Composite Index Constituent, Effective 7 September
- Metis TechBio-P (07666.HK): AiTEM AI Formulation Platform Partners with HENGRUI PHARMA to Accelerate Drug Formulation Development
- METIS TECHBIO-P(07666.HK) closed 14.34% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends
- METiS TechBio-P (07666.HK): Enters Global Licensing Collaboration with Deerfield for Trispecific TCE MTS-128 with Total Potential Value Up to US$1.6 Billion